![Paul Hopper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Hopper
Gründer bei
RADIOPHARM THERANOSTICS LIMITED
Vermögen: 594 394 $ am 30.09.2026
Profil
Mr. Paul A. Hopper is an Executive Chairman at Radiopharm Theranostics Ltd., an Executive Chairman at Imugene Ltd., a Managing Director at Cappello Group, Inc., a Chairman at Vaxinia Pty Ltd., a MD, Head-Life Sciences & Biotechnology Group at Cappello Global LLC, a Member at Pacific Council on International Policy and a President & Director at Radiopharm Theranostics (USA), Inc. He is on the Board of Directors at Biolife Science Ltd. and Radiopharm Theranostics (USA), Inc. Mr. Hopper was previously employed as an Independent Director by Scopus Biopharma, Inc., an Executive Chairman by Chimeric Therapeutics Ltd. (Australia), an Executive Chairman by Arovella Therapeutics Ltd., a Non-Executive Director by Respiri Ltd., a Non-Executive Chairman by Viralytics Pty Ltd., an Independent Director by EyePoint Pharmaceuticals, Inc., an Executive Chairman by Cell Aquaculture Ltd., an Independent Non-Executive Director by Somnomed Ltd., an Executive Chairman by Bone Medical Ltd., a Chief Operating Officer & Director by Acuvax Ltd., a Managing Director by Australian Cancer Technology Ltd., a Non-Executive Director by Prescient Therapeutics Ltd., a Managing Director by Alpha Healthcare Ltd., a Chairman-California Chapter by American Australian Association, an Executive Chairman by Bioscience Oncology Pty Ltd., a Founder by Glioblast Pty Ltd., a President by Innovate Oncology, Inc., a Founder by Pathway Oncology Pty Ltd., a Lead Director by Polynoma LLC, and a Managing Director by The Merchants Bank of New York.
He also served on the board at Fibrocell Science, Inc., Advanced Biotherapy, Inc., C19 Therapeutics Pty Ltd. and Medaire Ltd. He received his undergraduate degree from The University of New South Wales.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUGENE LTD 2.3% | 24.07.2025 | 12’614’263 ( 2.3% ) | 368 589 $ | 30.09.2026 |
| 30.06.2026 | 54’150’000 ( 1.15% ) | 225 806 $ | 30.09.2026 |
Aktive Positionen von Paul Hopper
| Unternehmen | Position | Beginn |
|---|---|---|
| IMUGENE LIMITED | Gründer | 31.10.2012 |
| RADIOPHARM THERANOSTICS LIMITED | Gründer | 01.01.2021 |
Vaxinia Pty Ltd.
 Vaxinia Pty Ltd. Pharmaceuticals: OtherHealth Technology Develops oncolytic cancer viruses | Vorsitzender | - |
Biolife Science Ltd.
 Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Manufactures cancer theraputic vaccines | Direktor/Vorstandsmitglied | - |
Pacific Council on International Policy
 Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Operates non-partisan membership based organization focused on foreign policy | Corporate Officer/Principal | - |
Cappello Global LLC
 Cappello Global LLC Investment Banks/BrokersFinance Provides advisory services | Corporate Officer/Principal | - |
Cappello Group, Inc.
 Cappello Group, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01.11.2005 |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Präsident | - |
Ehemalige bekannte Positionen von Paul Hopper
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Gründer | 25.11.2025 |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Paul Hopper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
33
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 33 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Cappello Group, Inc.
Cappello Group, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Advanced Biotherapy, Inc.
 Advanced Biotherapy, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Somnomed Ltd.
 Somnomed Ltd. Medical SpecialtiesHealth Technology Produces and distributes an oral device and anti-snoring device | Health Technology |
CAQ Holdings Ltd.
 CAQ Holdings Ltd. Real Estate DevelopmentFinance Provides property development and leasing services & retails diamonds and jewelry | Finance |
Medaire Ltd.
 Medaire Ltd. Specialty StoresRetail Trade Retails medical and orthopedic goods | Retail Trade |
Prescient Therapeutics Ltd.
 Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company | Health Technology |
Acuvax Ltd.
 Acuvax Ltd. Pharmaceuticals: OtherHealth Technology Develops cancer treatments and drug technologies | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Cappello Global LLC
Cappello Global LLC Investment Banks/BrokersFinance Provides advisory services | Finance |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
Innovate Oncology, Inc.
 Innovate Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Respiri Ltd.
 Respiri Ltd. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of medical devices | Health Technology |
Pacific Council on International Policy
Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Operates non-partisan membership based organization focused on foreign policy | Commercial Services |
American Australian Association
 American Australian Association Miscellaneous Commercial ServicesCommercial Services Promotes friendship, cooperation and understanding between the peoples of the United States and Australia | Commercial Services |
The Merchants Bank of New York
 The Merchants Bank of New York Regional BanksFinance Provides commercial banking services | Finance |
Polynoma LLC
 Polynoma LLC Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company that develops a novel vaccine for the adjuvant treatment of stage IIB and IIC melanoma | Health Technology |
Avantogen Ltd.
 Avantogen Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops cancer therapies | Commercial Services |
Alpha Healthcare Ltd.
 Alpha Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Provide consultancy, business support and advisory services | Commercial Services |
Biolife Science Ltd.
Biolife Science Ltd. Pharmaceuticals: OtherHealth Technology Manufactures cancer theraputic vaccines | Health Technology |
Pathway Oncology Pty Ltd.
 Pathway Oncology Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Holds license to anti-cancer technology | Commercial Services |
Glioblast Pty Ltd.
 Glioblast Pty Ltd. Pharmaceuticals: MajorHealth Technology Engages in neuro-oncology business | Health Technology |
Scopus Biopharma, Inc.
 Scopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company develops transformational therapeutics for serious diseases | Health Technology |
Vaxinia Pty Ltd.
Vaxinia Pty Ltd. Pharmaceuticals: OtherHealth Technology Develops oncolytic cancer viruses | Health Technology |
Chimeric Therapeutics Ltd. (Australia)
 Chimeric Therapeutics Ltd. (Australia) BiotechnologyHealth Technology Develops cell therapies for the tumors | Health Technology |
C19 Therapeutics Pty Ltd. | |
Bioscience Oncology Pty Ltd. | |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
